These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4015133)

  • 1. Etretinate therapy for psoriasis. Reduction of antibody-dependent cell-mediated cytotoxicity of polymorphonuclear leukocytes.
    Ellis CN; Kang S; Grekin RC; LoBuglio AF; Voorhees JJ
    Arch Dermatol; 1985 Jul; 121(7):877-80. PubMed ID: 4015133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of systemic etretinate treatment on natural cytotoxicity, immune angiogenesis and neutrophil adherence in patients with various forms of psoriasis.
    Majewski S; Wolska H; Jabłońska S; Wasik M
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):459-64. PubMed ID: 2484150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etretinate modulates the leukotriene B4 induced intra-epidermal accumulation of polymorphonuclear leukocytes.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Sep; 117(3):297-300. PubMed ID: 2823858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis.
    Schopf RE; Höcher J; Rehder M; Färber L; Morsches B
    Arch Dermatol Res; 1992; 284(4):227-31. PubMed ID: 1417069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of etretinate on chemotaxis of neutrophils from patients with pustular and vulgar psoriasis.
    Pigatto PD; Riva F; Altomare GF; Brugo AM; Morandotti A; Finzi AF
    J Invest Dermatol; 1983 Nov; 81(5):418-9. PubMed ID: 6631053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased urinary polyamines in patients with psoriasis treated with etretinate.
    Grekin RC; Ellis CN; Goldstein NG; Swanson NA; Anderson TF; Duell EA; Voorhees JJ
    J Invest Dermatol; 1983 Mar; 80(3):181-4. PubMed ID: 6827127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etretinate therapy and immune activities.
    Kang S; Ellis CN; Grekin RC; Hamilton TA; Voorhees JJ; LoBuglio AF
    Arch Dermatol; 1986 Jun; 122(6):629-30. PubMed ID: 3717974
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced monocyte and neutrophil cytotoxicity and normal cyclic nucleotide levels in severe psoriasis.
    Herlin T; Kragballe K
    Br J Dermatol; 1981 Oct; 105(4):405-13. PubMed ID: 6271161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Etretinate on the neutrophil chemotaxis in pustular psoriasis.
    Pigatto PD; Brugo AM; Finzi AF
    Boll Ist Sieroter Milan; 1982 May; 61(2):112-5. PubMed ID: 7126334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Unusual side effects in patients with psoriatic erythroderma treated with etretinate (RO 10-9359)].
    Castel T; Castro J; Lecha M; Mascaró JM
    Med Cutan Ibero Lat Am; 1986; 14(2):83-6. PubMed ID: 2943953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotretinoin vs etretinate therapy in generalized pustular and chronic psoriasis.
    Moy RL; Kingston TP; Lowe NJ
    Arch Dermatol; 1985 Oct; 121(10):1297-301. PubMed ID: 3862363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of psoriatic arthropathy with etretinate: a two-year follow-up.
    Chieregato GC; Leoni A
    Acta Derm Venereol; 1986; 66(4):321-4. PubMed ID: 2430403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Granulocyte migration in vitro in psoriasis patients induced by aromatic retinoid].
    Bauer R; Schütz R; Orfanos CE
    Z Hautkr; 1982 Sep; 57(17):1247-54. PubMed ID: 7148057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colchicine in generalized pustular psoriasis: clinical response and antibody-dependent cytotoxicity by monocytes and neutrophils.
    Zachariae H; Kragballe K; Herlin T
    Arch Dermatol Res; 1982; 274(3-4):327-33. PubMed ID: 6762163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etretinate therapy reduces inpatient treatment of psoriasis.
    Ellis CN; Hermann RC; Gorsulowsky DC; Goldfarb MT; Voorhees JJ
    J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):787-91. PubMed ID: 3680657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy for psoriasis with methotrexate and etretinate.
    Tuyp E; MacKie RM
    J Am Acad Dermatol; 1986 Jan; 14(1):70-3. PubMed ID: 3950115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte membrane phosphorylation in untreated and in etretinate-treated psoriatic patients.
    Kumar R; Weiss VC; West DP; Chiero LA
    Br J Dermatol; 1983 Sep; 109(3):277-86. PubMed ID: 6615715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose and insulin responses are improved in patients with psoriasis during therapy with etretinate.
    Ellis CN; Kang S; Vinik AI; Grekin RC; Cunningham WJ; Voorhees JJ
    Arch Dermatol; 1987 Apr; 123(4):471-5. PubMed ID: 3548599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.